2018 - February 22th -"The evolving phenotype of Li-Fraumeni Syndrome"
The evolving phenotype of Li-Fraumeni Syndrome
Huma Q. Rana, MD
Clinical Director, Cancer Genetics and Prevention
Dr. Huma Rana is a physician at Dana Farber Cancer Institute, board certified in Internal Medicine and Clinical Genetics. She received her medical degree from the Robert Wood Johnson Medical School, completed her Internal Medicine and Genetics training at Mount Sinai School of Medicine in New York, and joined Dana-Farber in 2012.
At Dana-Farber, she is the Clinical Director of the Center for Cancer Genetics and Prevention. She provides longitudinal medical management of patients with hereditary cancer predispositions, and also leads multiple research projects studying various hereditary cancer syndromes. She is currently leading a research study on genotype-phenotype correlations in Li-Fraumeni syndrome.